| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2024 | 226 | 1,047,756 | MSFT, OI, JPM, C | 13F-HR | 11/13/2024 | 000135482124000012 |
| Q2 2024 | 232 | 958,950 | MSFT, OI, JPM, JNJ | 13F-HR | 8/7/2024 | 000135482124000008 |
| Q1 2024 | 236 | 1,002,179 | MSFT, OI, JPM, HZO | 13F-HR | 5/16/2024 | 000135482124000006 |
| Q4 2023 | 247 | 926,977 | MSFT, UBSG.SW, JNJ, CAT | 13F-HR | 2/6/2024 | 000135482124000003 |
| Q3 2023 | 269 | 839,766 | MSFT, JNJ, CAT, JPM | 13F-HR | 10/31/2023 | 000135482123000008 |
| Q2 2023 | 273 | 880,836 | MSFT, CCK, JNJ, AAPL | 13F-HR | 7/31/2023 | 000135482123000006 |
| Q1 2023 | 242 | 806,669 | MSFT, CCK, JNJ, PCG | 13F-HR | 4/24/2023 | 000135482123000004 |
| Q4 2022 | 243 | 744,432 | OI, JNJ, MSFT, PCG | 13F-HR | 2/13/2023 | 000135482123000002 |
| Q3 2022 | 241 | 738,498 | OI, JNJ, MSFT, AAPL | 13F-HR | 11/8/2022 | 000135482122000011 |
| Q2 2022 | 276 | 845,892 | JNJ, AAPL, MSFT, T | 13F-HR | 8/15/2022 | 000135482122000009 |
| Q1 2022 | 328 | 1,037,026 | AAPL, MSFT, JNJ, T | 13F-HR | 5/2/2022 | 000135482122000007 |
| Q4 2021 | 337 | 1,070,407 | AAPL, MSFT, JNJ, JPM | 13F-HR | 2/15/2022 | 000135482122000005 |
| Q3 2021 | 365 | 1,000,945 | MSFT, AAPL, JPM, JNJ | 13F-HR | 11/10/2021 | 000135482121000013 |
| Q2 2021 | 372 | 980,809 | MSFT, AAPL, BC, JNJ | RESTATEMENT | 8/11/2021 | 000135482121000011 |
| Q1 2021 | 347 | 939,237 | MSFT, JPM, C, JNJ | 13F-HR | 5/4/2021 | 000135482121000008 |
| Q4 2020 | 303 | 893,783 | AAPL, MSFT, C, JNJ | 13F-HR | 2/16/2021 | 000135482121000004 |
| Q3 2020 | 268 | 764,161 | MSFT, AAPL, JNJ, JPM | 13F-HR | 11/17/2020 | 000135482120000008 |
| Q2 2020 | 192 | 727,775 | MSFT, JNJ, BC, AAPL | RESTATEMENT | 8/18/2020 | 000135482120000006 |
| Q1 2020 | 178 | 619,513 | MSFT, JNJ, JPM, AAPL | 13F-HR | 5/13/2020 | 000142050620000532 |
| Q4 2019 | 209 | 1,004,092 | MSFT, C, AERIE PHARMACEUTICALS INC, JPM | 13F-HR | 2/10/2020 | 000142050620000112 |
| Q3 2019 | 204 | 905,182 | MSFT, C, CVA, GM | 13F-HR | 11/14/2019 | 000142050619001159 |
| Q2 2019 | 210 | 1,013,176 | MSFT, C, PFE, CVA | 13F-HR | 8/13/2019 | 000142050619000806 |
| Q1 2019 | 193 | 891,836 | MSFT, DUPONT INC, C, CVA | 13F-HR | 5/13/2019 | 000106299319002151 |
| Q4 2018 | 258 | 4,540,343 | DD, GM, OXY, T | 13F-HR | 2/5/2019 | 000106299319000507 |
| Q3 2018 | 280 | 5,813,215 | C, PFE, OXY, DD | 13F-HR | 10/29/2018 | 000106299318004246 |
| Q2 2018 | 293 | 5,798,501 | C, DD, OXY, T | 13F-HR | 8/7/2018 | 000106299318003151 |
| Q1 2018 | 311 | 5,497,369 | C, PFE, DD, T | 13F-HR | 5/18/2018 | 000106299318002311 |
| Q4 2017 | 307 | 5,919,256 | PFE, C, DD, NOK | 13F-HR | 2/9/2018 | 000106299318000573 |
| Q3 2017 | 345 | 5,900,345 | PFE, C, NOK, INTC | 13F-HR | 11/13/2017 | 000106299317004829 |
| Q2 2017 | 313 | 5,727,424 | C, PFE, INTC, NOK | 13F-HR | 8/11/2017 | 000106299317003697 |
| Q1 2017 | 303 | 5,607,512 | C, PFE, INTC, NOK | RESTATEMENT | 5/24/2017 | 000106299317002670 |
| Q4 2016 | 303 | 5,822,153 | C, PFE, NOK, OXY | 13F-HR | 2/14/2017 | 000106299317000918 |
| Q3 2016 | 334 | 6,799,317 | SYF, C, PFE, NOK | 13F-HR | 11/14/2016 | 000106299316012249 |
| Q2 2016 | 337 | 5,548,030 | EMC, GLW, DOW, C | 13F-HR | 8/12/2016 | 000106299316011068 |
| Q1 2016 | 326 | 5,524,424 | PFE, EMC, GLW, DOW | 13F-HR | 5/13/2016 | 000106299316009702 |
| Q4 2015 | 346 | 5,690,910 | PFE, EMC, DOW, C | 13F-HR | 2/10/2016 | 000106299316007611 |
| Q3 2015 | 365 | 5,862,542 | C, EMC, PFE, GE | 13F-HR | 11/13/2015 | 000106299315006042 |
| Q2 2015 | 378 | 6,762,030 | C, ETN, EMC, PF | 13F-HR | 8/12/2015 | 000106299315004362 |
| Q1 2015 | 388 | 6,677,180 | C, PFE, ETN, EMC | 13F-HR | 5/12/2015 | 000106299315002600 |
| Q4 2014 | 382 | 6,617,172 | PFE, ETN, GE, C | 13F-HR | 2/12/2015 | 000106299315000670 |
| Q3 2014 | 337 | 6,570,226 | PFE, GE, C, ETN | 13F-HR | 11/12/2014 | 000106299314006502 |
| Q2 2014 | 346 | 6,487,061 | PFE, GE, ETN, C | 13F-HR | 8/13/2014 | 000106299314004782 |
| Q1 2014 | 326 | 5,965,533 | ETN, GE, PFE, MRK | 13F-HR | 5/14/2014 | 000106299314002830 |
| Q4 2013 | 319 | 6,213,690 | GE, ETN, C, PFE | 13F-HR | 2/13/2014 | 000106299314000790 |